Related references
Note: Only part of the references are listed.Alternative polyadenylation of mRNA precursors
Bin Tian et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
The alternative life of RNA-sequencing meets single molecule approaches
Sandra M. Fernandez-Moya et al.
FEBS LETTERS (2017)
The highly expressed 5′isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration
Omar Salem et al.
BMC GENOMICS (2016)
Alternative Polyadenylation: Another Foe in Cancer
Ayse Elif Erson-Bensan et al.
MOLECULAR CANCER RESEARCH (2016)
Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas
Jeremy T-H. Chang et al.
PLOS ONE (2016)
Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients
Fausto Petrelli et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
The relevance of EMT in breast cancer metastasis: Correlation or causality?
Ruben Bill et al.
FEBS LETTERS (2015)
Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer
Jason R. Brown et al.
LABORATORY INVESTIGATION (2014)
CFIm25 links alternative polyadenylation to glioblastoma tumour suppression
Chioniso P. Masamha et al.
NATURE (2014)
Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′- UTR landscape across seven tumour types
Zheng Xia et al.
NATURE COMMUNICATIONS (2014)
Alternative cleavage and polyadenylation: extent, regulation and function
Ran Elkon et al.
NATURE REVIEWS GENETICS (2013)
Interactive exploration of RNA22 microRNA target predictions
Phillipe Loher et al.
BIOINFORMATICS (2012)
Shortening of 3′UTRs Correlates with Poor Prognosis in Breast and Lung Cancer
Antonio Lembo et al.
PLOS ONE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Differential genome-wide profiling of tandem 3′ UTRs among human breast cancer and normal cells by high-throughput sequencing
Yonggui Fu et al.
GENOME RESEARCH (2011)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Expanding the MicroRNA Targeting Code: Functional Sites with Centered Pairing
Chanseok Shin et al.
MOLECULAR CELL (2010)
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer
M. Colleoni et al.
ANNALS OF ONCOLOGY (2009)
Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells
Christine Mayr et al.
CELL (2009)
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
Matthew J. Ellis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
E. de Azambuja et al.
BRITISH JOURNAL OF CANCER (2007)
A large-scale analysis of mRNA polyadenylation of human and mouse genes
B Tian et al.
NUCLEIC ACIDS RESEARCH (2005)
Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy
T Petit et al.
EUROPEAN JOURNAL OF CANCER (2004)
Share Paper
